KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Total Liabilities: 2009-2025

Historic Total Liabilities for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to $1.3 billion.

  • Novavax's Total Liabilities fell 40.30% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 40.30%. This contributed to the annual value of $2.2 billion for FY2024, which is 13.13% down from last year.
  • Latest data reveals that Novavax reported Total Liabilities of $1.3 billion as of Q3 2025, which was up 2.90% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, Novavax's Total Liabilities peaked at $3.0 billion during Q2 2022, and registered a low of $1.3 billion during Q2 2025.
  • For the 3-year period, Novavax's Total Liabilities averaged around $2.1 billion, with its median value being $2.2 billion (2024).
  • As far as peak fluctuations go, Novavax's Total Liabilities spiked by 345.76% in 2021, and later plummeted by 42.28% in 2025.
  • Novavax's Total Liabilities (Quarterly) stood at $2.9 billion in 2021, then dropped by 1.22% to $2.9 billion in 2022, then dropped by 13.08% to $2.5 billion in 2023, then declined by 13.13% to $2.2 billion in 2024, then tumbled by 40.30% to $1.3 billion in 2025.
  • Its Total Liabilities stands at $1.3 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.4 billion for Q1 2025.